Perfusio’s imaging platform is grounded in decades of research with more than $20 million in funding from the NIH and Department of Defense. It has been validated in multiple preclinical studies and successfully applied to both burn and wound care. This proprietary AI-powered perfusion imaging system is the first of its kind to provide bedside visualization of tissue viability in real time. With a functional prototype already developed, Perfusio is positioned to advance rapidly toward clinical trials and regulatory submission.

Burn injuries are among the most frequent and complex medical traumas, impacting over 450,000 people each year in the United States. Despite this, most clinical assessments still rely on visual inspection alone, which leads to misdiagnosis in up to half of all cases. The consequences are serious, including unnecessary surgeries, prolonged hospital stays, and significant healthcare costs. Clinicians need a more accurate, data-driven approach to evaluating burn depth and tissue health—especially in fast-paced and resource-limited environments.

Perfusio is actively seeking a strategic partner to help bring this technology to market. We are ready to align on system design, clinical study planning, and regulatory strategy. Our ideal partner is forward-thinking and shares our mission to transform wound diagnostics. Together, we can introduce a new standard of care that improves patient outcomes and reduces healthcare costs across emergency departments, burn units, and military medical teams.